Primary knee arthroplasty using recombinant factor VIIa (rFVIIa) as first-line therapy in hemophilia patients with high responding inhibitors: the Eureka study / Y. Laurian, L. Solimeno, R. Nunez, A. Kurth, V. Molina, V. Jimenez-Juste, N. Goddard, E. Santagostino, G. Tagariello, M. Morfini. - In: HAEMOPHILIA. - ISSN 1351-8216. - 14:2(2008 Mar), pp. 400-401. ( 10. Musculoskeletal Congress of the World Federation of Hemophilia (WFH) : May 3–6, Stresa 2007).
Primary knee arthroplasty using recombinant factor VIIa (rFVIIa) as first-line therapy in hemophilia patients with high responding inhibitors: the Eureka study
L. SolimenoSecondo
;
2008
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
haemophilia+vol+14+s2+p400-402(2)(1).pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
52.2 kB
Formato
Adobe PDF
|
52.2 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
